Tonnus, W.* ; Meyer, C.* ; Steinebach, C.* ; Belavgeni, A.* ; von Mässenhausen, A.* ; Gonzalez, N.Z.* ; Maremonti, F.* ; Gembardt, F.* ; Himmerkus, N.* ; Latk, M.* ; Locke, S.* ; Marschner, J.A.* ; Li, W.* ; Short, S.C.* ; Doll, S. ; Ingold, I. ; Proneth, B. ; Daniel, C.* ; Kabgani, N.* ; Kramann, R.* ; Motika, S.* ; Hergenrother, P.J.* ; Bornstein, S.R. ; Hugo, C.* ; Becker, J.U.* ; Amann, K.* ; Anders, H.J.* ; Kreisel, D.* ; Pratt, D.A.* ; Gütschow, M.* ; Conrad, M. ; Linkermann, A.*
Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury.
Nat. Commun. 12:4402 (2021)
Acute kidney injury (AKI) is morphologically characterized by a synchronized plasma membrane rupture of cells in a specific section of a nephron, referred to as acute tubular necrosis (ATN). Whereas the involvement of necroptosis is well characterized, genetic evidence supporting the contribution of ferroptosis is lacking. Here, we demonstrate that the loss of ferroptosis suppressor protein 1 (Fsp1) or the targeted manipulation of the active center of the selenoprotein glutathione peroxidase 4 (Gpx4cys/-) sensitize kidneys to tubular ferroptosis, resulting in a unique morphological pattern of tubular necrosis. Given the unmet medical need to clinically inhibit AKI, we generated a combined small molecule inhibitor (Nec-1f) that simultaneously targets receptor interacting protein kinase 1 (RIPK1) and ferroptosis in cell lines, in freshly isolated primary kidney tubules and in mouse models of cardiac transplantation and of AKI and improved survival in models of ischemia-reperfusion injury. Based on genetic and pharmacological evidence, we conclude that GPX4 dysfunction hypersensitizes mice to ATN during AKI. Additionally, we introduce Nec-1f, a solid inhibitor of RIPK1 and weak inhibitor of ferroptosis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Cell-death; Necroptosis; Mlkl; Gpx4; Generation; Clearance; Mechanism; Pathways
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 12,
Issue: 1,
Pages: ,
Article Number: 4402
Supplement: ,
Series
Publisher
Nature Publishing Group
Publishing Place
London
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
90000 - German Center for Diabetes Research
Research field(s)
Genetics and Epidemiology
Helmholtz Diabetes Center
PSP Element(s)
G-506900-001
G-502600-007
Grants
SFB 1350 TP C2
transCampus initiative of S.R.B
German Research Foundation (DFG)
international research training group (IRTG)
DFG
German Federal Ministry of Education and Research (BMBF) VIP + program
SPP2306
SFB-TRR 127
SFB-TRR 205
European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program
Bavarian Ministry of Economic Affairs, Regional Development and Energy (StMWi)
Else Kroner-Fresenius-Stiftung
Ministry of Science and Higher Education of The Russian Federation
Helmholtz Validation Fund
Medical Clinic 3, University Hospital Carl Gustav Carus Dresden, Germany
Copyright
Erfassungsdatum
2021-08-06